SEC Form 4 · accession 0000899243-16-011450
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith S Ehrlich
Officer — Chief Financial Officer
Period of report
Jan 7, 2016
Accepted (ET)
Jan 11, 2016 · 1:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.08 | Jan 7, 2016 | A | 149,500 | A | — | Jan 7, 2026 | Common Stock | 149,500 | 149,500 | D |
Explanation of responses
- F1The shares underlying this option vest in equal monthly installments from January 7, 2016, through January 7, 2020, subject to the Reporting Person's continued service to the Company.